Heparin resistance during membrane plasmapheresis.
Yamashita
M
M
Cleveland Clinic Foundation, One Clinic Center, Ohio 44195-5132.
Omokawa
S
S
Lucas
F V
FV
Takeyama
Y
Y
Goldcamp
J B
JB
Koo
A P
AP
Malchesky
P S
PS
Nosè
Y
Y
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000628:therapy; D001777:Blood Coagulation / Q000187:drug effects; D003449:Cryoglobulinemia / Q000097:blood / Q000628:therapy; D004351:Drug Resistance; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis / Q000009:adverse effects* / Q000379:methods
D006493:Heparin